BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 32016883)

  • 1. Current and Future Challenges in Modern Drug Discovery.
    Tautermann CS
    Methods Mol Biol; 2020; 2114():1-17. PubMed ID: 32016883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. User-Friendly Quantum Mechanics: Applications for Drug Discovery.
    Kotev M; Sarrat L; Gonzalez CD
    Methods Mol Biol; 2020; 2114():231-255. PubMed ID: 32016897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QM Implementation in Drug Design: Does It Really Help?
    Liu J; He X
    Methods Mol Biol; 2020; 2114():19-35. PubMed ID: 32016884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Next for Quantum Mechanics in Structure-Based Drug Discovery?
    Bryce RA
    Methods Mol Biol; 2020; 2114():339-353. PubMed ID: 32016902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The convergence of artificial intelligence and chemistry for improved drug discovery.
    Green CP; Engkvist O; Pairaudeau G
    Future Med Chem; 2018 Nov; 10(22):2573-2576. PubMed ID: 30499699
    [No Abstract]   [Full Text] [Related]  

  • 6. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
    Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
    Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
    Meanwell NA
    Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding Free Energy Calculation Using Quantum Mechanics Aimed for Drug Lead Optimization.
    Cavasotto CN
    Methods Mol Biol; 2020; 2114():257-268. PubMed ID: 32016898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence Teaches Drugs to Target Proteins by Tackling the Induced Folding Problem.
    Fernández A
    Mol Pharm; 2020 Aug; 17(8):2761-2767. PubMed ID: 32551659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Approaches for De Novo Drug Design: Past, Present, and Future.
    Liu X; IJzerman AP; van Westen GJP
    Methods Mol Biol; 2021; 2190():139-165. PubMed ID: 32804364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational medicine--a paradigm shift in modern drug discovery and development: the role of biomarkers.
    Day M; Rutkowski JL; Feuerstein GZ
    Adv Exp Med Biol; 2009; 655():1-12. PubMed ID: 20047030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact, determination and prediction of drug-receptor residence times for GPCRs.
    Tautermann CS
    Curr Opin Pharmacol; 2016 Oct; 30():22-26. PubMed ID: 27428776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automating drug discovery.
    Schneider G
    Nat Rev Drug Discov; 2018 Feb; 17(2):97-113. PubMed ID: 29242609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.